Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Motilin
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Motilin

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 5 min read

A peptide of about 22-amino acids isolated from the duodenum.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (944 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A peptide of about 22-amino acids isolated from the duodenum. At low pH it inhibits gastric motor activity, whereas at high pH it has a stimulating effect.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Where it fits in the MeSH classification

Broader topics
Gastrointestinal Hormones; Peptide Hormones; Neuropeptides

Related concepts

  • Duodenum

Research landscape

PubMed indexes 1,378 records tagged with the MeSH heading “Motilin” (counts retrieved 2026-10-31). 81 of them (5.9%) were published from 2020 onward, and the busiest period so far is through 1999 with 858 records.

Reviews account for 145 records (10.5%) and meta-analyses for 2. Randomized controlled trials number 107 (7.8%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 858 records; 2000-2009: 275 records; 2010-2019: 164 records; 2020 onward: 81 records858through 19992752000-20091642010-2019812020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999858
2000-2009275
2010-2019164
2020 onward81
Share of records by publication typeReviews: 10.5 percent; Meta-analyses: 0.1 percent; Randomized controlled trials: 7.8 percentReviews10.5% (145)Meta-analyses0.1% (2)Randomized controlled trials7.8% (107)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 1,378 PubMed records
TypeRecordsShare
Reviews14510.5%
Meta-analyses20.1%
Randomized controlled trials1077.8%

Method: PubMed query "Motilin"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Motilin Comparative Study: Structure, Distribution, Receptors, and Gastrointestinal Motility
Kitazawa T, Kaiya H
2021Review article
Design not recorded in structured metadata
45cc by
PMID 34497583 · DOI · PMC8419268
The role of the vagus nerve in the migrating motor complex and ghrelin- and motilin-induced gastric contraction in suncus
Miyano Y, Sakata I, Kuroda K, Aizawa S, Tanaka T, Jogahara T, et al.
2013Research article
Design not recorded in structured metadata
41cc by
PMID 23724093 · DOI · PMC3665597
Stimulation of motilin secretion by bile, free fatty acids, and acidification in human duodenal organoids
Miedzybrodzka EL, Foreman RE, Lu VB, George AL, Smith CA, Larraufie P, et al.
2021Research article
Design not recorded in structured metadata
23cc by
PMID 34662713 · DOI · PMC8590067
Motilin fluctuations in healthy volunteers determined by liquid chromatography mass spectrometry
Foreman RE, Bannon CA, Kay RG, Reimann F, Gribble FM
2024Research article
Design not recorded in structured metadata
3cc by
PMID 38544692 · DOI · PMC10965782

Motilin Comparative Study: Structure, Distribution, Receptors, and Gastrointestinal Motility [1]

Review article Kitazawa T, Kaiya H · · 2021 · cited 45 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Motilin, produced in endocrine cells in the mucosa of the upper intestine, is an important regulator of gastrointestinal (GI) motility and mediates the phase III of interdigestive migrating motor complex (MMC) in the stomach of humans, dogs and house musk shrews through the specific motilin receptor (MLN-R).
Closing excerpt
Almost 50 years have passed since discovery of motilin, here we reviewed the structure, distribution, receptor and the GI motility regulatory function of motilin in vertebrates from fish to mammals.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (192 words)

Motilin, produced in endocrine cells in the mucosa of the upper intestine, is an important regulator of gastrointestinal (GI) motility and mediates the phase III of interdigestive migrating motor complex (MMC) in the stomach of humans, dogs and house musk shrews through the specific motilin receptor (MLN-R). Motilin-induced MMC contributes to the maintenance of normal GI functions and transmits a hunger signal from the stomach to the brain. Motilin has been identified in various mammals, but the physiological roles of motilin in regulating GI motility in these mammals are well not understood due to inconsistencies between studies conducted on different species using a range of experimental conditions. Motilin orthologs have been identified in non-mammalian vertebrates, and the sequence of avian motilin is relatively close to that of mammals, but reptile, amphibian and fish motilins show distinctive different sequences. The MLN-R has also been identified in mammals and non-mammalian vertebrates, and can be divided into two main groups: mammal/bird/reptile/amphibian clade and fish clade. Almost 50 years have passed since discovery of motilin, here we reviewed the structure, distribution, receptor and the GI motility regulatory function of motilin in vertebrates from fish to mammals.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 34497583 · DOI · PMC8419268

The role of the vagus nerve in the migrating motor complex and ghrelin- and motilin-induced gastric contraction in suncus [2]

Research article Miyano Y, Sakata I, Kuroda K, Aizawa S, Tanaka T, Jogahara T, et al. · · 2013 · cited 41 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
The upper gastrointestinal (GI) tract undergoes a temporally coordinated cyclic motor pattern known as the migrating motor complex (MMC) in both dogs and humans during the fasted state.
Closing excerpt
Furthermore, the vagus nerve is essential for initiating postprandial contractions, and inhibition of the phase III-like contractions induced by motilin is highly dependent on the vagus nerve.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (285 words)

The upper gastrointestinal (GI) tract undergoes a temporally coordinated cyclic motor pattern known as the migrating motor complex (MMC) in both dogs and humans during the fasted state. Feeding results in replacement of the MMC by a pattern of noncyclic, intermittent contractile activity termed as postprandial contractions. Although the MMC is known to be stimulated by motilin, recent studies have shown that ghrelin, which is from the same peptide family as motilin, is also involved in the regulation of the MMC. In the present study, we investigated the role of the vagus nerve on gastric motility using conscious suncus-a motilin- and ghrelin-producing small animal. During the fasted state, cyclic MMC comprising phases I, II, and III was observed in both sham-operated and vagotomized suncus; however, the duration and motility index (MI) of phase II was significantly decreased in vagotomized animals. Motilin infusion (50 ng·kg(-1)·min(-1) for 10 min) during phase I had induced phase III-like contractions in both sham-operated and vagotomized animals. Ghrelin infusion (0.1, 0.3, 1, 3, or 10 µg·kg(-1)·min(-1) for 10 min) enhanced the amplitude of phase II MMC in sham-operated animals, but not in vagotomized animals. After feeding, phase I was replaced by postprandial contractions, and motilin infusion (50 ng·kg(-1)·min(-1) for 10 min) did not induce phase III-like contractions in sham-operated suncus. However, in vagotomized suncus, feeding did not evoke postprandial contractions, but exogenous motilin injection strongly induced phase III-like contractions, as noted during the phase I period. Thus, the results indicate that ghrelin stimulates phase II of the MMC via the vagus nerve in suncus. Furthermore, the vagus nerve is essential for initiating postprandial contractions, and inhibition of the phase III-like contractions induced by motilin is highly dependent on the vagus nerve.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 23724093 · DOI · PMC3665597

Stimulation of motilin secretion by bile, free fatty acids, and acidification in human duodenal organoids [3]

Research article Miedzybrodzka EL, Foreman RE, Lu VB, George AL, Smith CA, Larraufie P, et al. · · 2021 · cited 23 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
ObjectiveMotilin is a proximal small intestinal hormone with roles in gastrointestinal motility, gallbladder emptying, and hunger initiation.
Closing excerpt
We identify several receptors important for the postprandial and interdigestive regulation of motilin release.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (230 words)

ObjectiveMotilin is a proximal small intestinal hormone with roles in gastrointestinal motility, gallbladder emptying, and hunger initiation. In vivo motilin release is stimulated by fats, bile, and duodenal acidification but the underlying molecular mechanisms of motilin secretion remain poorly understood. This study aimed to establish the key signaling pathways involved in the regulation of secretion from human motilin-expressing M-cells.MethodsHuman duodenal organoids were CRISPR-Cas9 modified to express the fluorescent protein Venus or the Ca2+ sensor GCaMP7s under control of the endogenous motilin promoter. This enabled the identification and purification of M-cells for bulk RNA sequencing, peptidomics, calcium imaging, and electrophysiology. Motilin secretion from 2D organoid-derived cultures was measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS), in parallel with other gut hormones.ResultsHuman duodenal M-cells synthesize active forms of motilin and acyl-ghrelin in organoid culture, and also co-express cholecystokinin (CCK). Activation of the bile acid receptor GPBAR1 stimulated a 3.4-fold increase in motilin secretion and increased action potential firing. Agonists of the long-chain fatty acid receptor FFA1 and monoacylglycerol receptor GPR119 stimulated secretion by 2.4-fold and 1.5-fold, respectively. Acidification (pH 5.0) was a potent stimulus of M-cell calcium elevation and electrical activity, an effect attributable to acid-sensing ion channels, and a modest inducer of motilin release.ConclusionsThis study presents the first in-depth transcriptomic and functional characterization of human duodenal motilin-expressing cells. We identify several receptors important for the postprandial and interdigestive regulation of motilin release.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 34662713 · DOI · PMC8590067

Motilin fluctuations in healthy volunteers determined by liquid chromatography mass spectrometry [4]

Research article Foreman RE, Bannon CA, Kay RG, Reimann F, Gribble FM · · 2024 · cited 3 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
IntroductionMotilin is a hormone secreted by specialised enteroendocrine cells in the small intestine, and is known to modulate gastrointestinal motility in humans, regulating the migratory motor complex.
Closing excerpt
This analytical method has utility for further clinical studies into motilin and gut hormone physiology in human volunteers.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (237 words)

IntroductionMotilin is a hormone secreted by specialised enteroendocrine cells in the small intestine, and is known to modulate gastrointestinal motility in humans, regulating the migratory motor complex. It is understudied at least in part due to the lack of commercially available immunoassays.MethodA multiplexed liquid chromatography mass spectrometry (LC-MS/MS) method was optimised to measure motilin, insulin, C-peptide, GIP (1-42) and GIP (3-42). Corresponding active ghrelin concentrations were determined by immunoassay. Ten healthy volunteers with no prior history of gastroenterological or endocrine condition attended after overnight fast and had blood samples taken every 15 minutes for 4 hours whilst continuing to fast, and then further sampling for 2 hours following a liquid mixed meal. Hunger scores were taken at each time point using a visual analogue scale. Normal bowel habit was confirmed by 1 week stool diary.ResultsMotilin levels fluctuated in the fasting state with an average period between peaks of 109.5 mins (SD:30.0), but with no evidence of a relationship with either ghrelin levels or hunger scores. The mixed meal interrupted cyclical motilin fluctuations, increased concentrations of motilin, insulin, C-peptide, GIP(1-42) and GIP(3-42), and suppressed ghrelin levels.DiscussionThis study highlights the utility of LC-MS/MS for parallel measurement of motilin alongside other peptide hormones, and supports previous reports of the cyclical nature of motilin levels in the fasting state and interruption with feeding. This analytical method has utility for further clinical studies into motilin and gut hormone physiology in human volunteers.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 38544692 · DOI · PMC10965782

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Motilin and clinical application [5]
    Itoh Z · Peptides · 1997 · cited 179 times (Europe PMC)
  • Research article Erythromycin and other macrolides as prokinetic agents [6]
    Peeters TL · Gastroenterology · 1993 · cited 161 times (Europe PMC)
  • Research article The translational value of rodent gastrointestinal functions: a cautionary tale [7]
    Sanger GJ, Holbrook JD, Andrews PL · Trends Pharmacol Sci · 2011 · cited 90 times (Europe PMC)
  • Research article Erythromycin: a motilin agonist and gastrointestinal prokinetic agent [8]
    Weber FH, Richards RD, McCallum RW · Am J Gastroenterol · 1993 · cited 87 times (Europe PMC)
  • Research article Motilin: from gastric motility stimulation to hunger signalling [9]
    Deloose E, Verbeure W, Depoortere I, Tack J · Nat Rev Endocrinol · 2019 · cited 60 times (Europe PMC)
  • Research article Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases [10]
    Sanger GJ · Drug Discov Today · 2008 · cited 56 times (Europe PMC)

References

  1. Kitazawa T, Kaiya H. Motilin Comparative Study: Structure, Distribution, Receptors, and Gastrointestinal Motility. . 2021. PMID 34497583 · DOI · PMC8419268
  2. Miyano Y, Sakata I, Kuroda K, Aizawa S, Tanaka T, Jogahara T, et al.. The role of the vagus nerve in the migrating motor complex and ghrelin- and motilin-induced gastric contraction in suncus. . 2013. PMID 23724093 · DOI · PMC3665597
  3. Miedzybrodzka EL, Foreman RE, Lu VB, George AL, Smith CA, Larraufie P, et al.. Stimulation of motilin secretion by bile, free fatty acids, and acidification in human duodenal organoids. . 2021. PMID 34662713 · DOI · PMC8590067
  4. Foreman RE, Bannon CA, Kay RG, Reimann F, Gribble FM. Motilin fluctuations in healthy volunteers determined by liquid chromatography mass spectrometry. . 2024. PMID 38544692 · DOI · PMC10965782
  5. Itoh Z. Motilin and clinical application. Peptides. 1997. PMID 9210180 · DOI
  6. Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology. 1993. PMID 8253365 · DOI
  7. Sanger GJ, Holbrook JD, Andrews PL. The translational value of rodent gastrointestinal functions: a cautionary tale. Trends Pharmacol Sci. 2011. PMID 21531468 · DOI
  8. Weber FH, Richards RD, McCallum RW. Erythromycin: a motilin agonist and gastrointestinal prokinetic agent. Am J Gastroenterol. 1993. PMID 8470625
  9. Deloose E, Verbeure W, Depoortere I, Tack J. Motilin: from gastric motility stimulation to hunger signalling. Nat Rev Endocrinol. 2019. PMID 30675023 · DOI
  10. Sanger GJ. Motilin, ghrelin and related neuropeptides as targets for the treatment of GI diseases. Drug Discov Today. 2008. PMID 18342799 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • SecretinDrugs and Chemicals
  • TirzepatideDrugs and Chemicals
  • Vasoactive Intestinal PeptideDrugs and Chemicals
  • Adrenocorticotropic HormoneDrugs and Chemicals
  • Angiotensin IDrugs and Chemicals
  • Angiotensin IIDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

1,378
PubMed records on this heading
6%
published since 2020
145
review articles
107
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • SecretinDrugs and Chemicals
  • TirzepatideDrugs and Chemicals
  • Vasoactive Intestinal PeptideDrugs and Chemicals
  • Adrenocorticotropic HormoneDrugs and Chemicals
  • Angiotensin IDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support